All In MedTech

Company

iRhythm Technologies

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

iRhythm Technologies is on our public-company list (ticker IRTC). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

IRTC

Nasdaq · iRhythm Holdings, Inc.

Public float

$4.90B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$747M

Fiscal year ending Dec 31, 2025

Net income

-$44.6M

Fiscal year ending Dec 31, 2025

R&D spending

$84.6M

Fiscal year ending Dec 31, 2025

Cash

$395M

As of Sep 30, 2026

Long-term debt

$652M

As of Sep 30, 2026

Shares outstanding

33.6M

As of Oct 29, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2024–––$661M

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
May 16, 2014Equity$27.3M$29.5M10Rule 506(b)Form D/A ↗Mar 16, 20151 amendment
Mar 27, 2013Equity$15.1M$17.0M17Rule 506Form D ↗Apr 8, 2013
Nov 1, 2012Convertible note$3.5M$3.5M16Rule 506Form D ↗Nov 13, 2012

3 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
iRhythm Technologies, Inc.
Headquarters
San Francisco, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    8 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For iRhythm Technologies we have 4 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 12 since 2015.

    Search the Clearance Tracker

    9 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT07205367 · 150 participants · Start Jan 6, 2025 · Primary completion Jul 29, 2025

      Device: Zio Monitor · For: Cardiac Arrhythmia

      Sites: San Francisco, California; Deerfield, Illinois

    • NCT07118124 · 36 participants · Start Aug 15, 2025 · Primary completion Sep 26, 2025

      Device: Zio monitor · For: Syncope; Pediatric; Congenital Athymia and 3 more

      Sites: Washington D.C., District of Columbia; Boise, Idaho; Boston, Massachusetts · 4 sites in all

    • NCT04056715 · 250 participants · Start Jan 14, 2020 · Primary completion Apr 18, 2022

      Device: Zio XT · For: Hypertrophic Cardiomyopathy; Nonsustained Ventricular Tachycardia; Ventricular Tachycardia and 2 more

      Sites: Boston, Massachusetts

    Reports received

    288

    Received Nov 1, 2025 to Nov 20, 2026. Includes 2 of another or unstated type.

    Malfunction reports

    52

    18% of reports

    Injury reports

    233

    81% of reports

    Death reports

    1

    0.3% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 2361800
    Jan 2441540
    Feb 2443520
    Mar 2449230
    Apr 2459200
    May 2463200
    Jun 2493230
    Jul 246700
    Aug 24151100
    Sep 2410500
    Oct 2414900
    Nov 2451210
    Dec 24131310
    Jan 2571500
    Feb 2561400
    Mar 2591310
    Apr 25101800
    May 2571100
    Jun 2511700
    Jul 2581700
    Aug 2543100
    Sep 2532900
    Oct 2521400
    Nov 2552300
    Dec 2553900
    Jan 26102510
    Feb 2664300
    Mar 2633000
    Apr 2694300
    May 2612500
    Jun 269100
    Jul 262300
    Aug 262102
    Sep 260000
    Oct 260000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.